General Atlantic, Aquitaine, Avesi, PPC Enterprises target speech therapy; Stable pharmaceutical demand leads SK Capital-backed Apotex to C$1.3bn IPO

AI Summary

Private equity firms General Atlantic, Aquitaine, Avesi, and PPC Enterprises are targeting speech therapy markets amid rising early intervention diagnoses in children. SK Capital-backed Apotex launched the largest life sciences IPO in Toronto Stock Exchange history at C$1.3 billion.

Early intervention is leading to more diagnoses in children of conditions that require speech therapy, fueling demand in the segment and catching the eye of private equity; discussing the largest life sciences IPO in the Toronto Stock Exchange’s history, launched by SK Capital-backed Apotex. The post General Atlantic, Aquitaine, Avesi, PPC Enterprises target speech therapy; Stable pharmaceutical demand leads SK Capital-backed Apotex to C$1.3bn IPO appeared first on PE Hub.